Finance

Lists
Why is 600613 down 5.50%?
Dive Deeper
600613:SHA
Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CN¥8.24
-5.50%
(-0.48) 1D
Oct 12, 10:01:02 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600613...
Open
CN¥8.52
High
CN¥8.72
Low
CN¥8.21
Mkt. cap
4.34B
Avg. vol.
105.46M
Volume
34.29M
Dividend
0.85%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
160.66
52-wk high
CN¥12.77
52-wk low
CN¥4.33
EPS
CN¥0.05
Shares outstanding
479.32M
No. of employees
1K
Open
CN¥8.52
High
CN¥8.72
Low
CN¥8.21
Mkt. cap
4.34B
Avg. vol.
105.46M
Volume
34.29M
Dividend
0.85%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
160.66
52-wk high
CN¥12.77
52-wk low
CN¥4.33
EPS
CN¥0.05
Shares outstanding
479.32M
No. of employees
1K
News stories
From web sources and news partners
About Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CEO-
Employees1.2K
FoundedJul 22, 1992
Headquarters-
SectorPharmaceutical industry
Websitegzsq.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
437.01M
554.51M
422.94M
425.19M
Cost of goods sold
221.29M
348.47M
232.06M
255.15M
Cost of revenue
221.29M
348.47M
232.06M
255.15M
Research and development expenses
7.91M
8.48M
7.04M
7.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169.03M
186.17M
148.02M
136.08M
Operating expense
185.83M
211.87M
169.08M
148.61M
Total operating expenses
407.11M
560.34M
401.14M
403.76M
Operating income
29.90M
-5.83M
21.80M
21.43M
Other non operating income
-1.06M
-1.07M
-1.84M
-340.06K
EBT including unusual items
19.70M
5.71M
19.41M
17.69M
EBT excluding unusual items
29.63M
-5.90M
19.66M
21.75M
Income tax expense
3.03M
16.97M
7.38M
4.21M
Effective tax rate
15.36%
296.96%
38.03%
23.82%
Other operating expenses
8.98M
3.52M
9.92M
3.29M
Net income
17.49M
-12.06M
12.88M
9.08M
Net profit margin
4.00%
-2.17%
3.05%
2.14%
Earnings per share
-
-
-
-
Interest and investment income
1.85M
4.08M
2.07M
716.57K
Interest expense
-1.07M
-3.10M
-2.37M
-55.63K
Net interest expenses
783.54K
983.79K
-305.41K
660.94K
Depreciation and amortization charges
-
-
-
-
EBITDA
49.34M
12.75M
40.38M
41.62M
Gain or loss from assets sale
-
-227.96K
-
-51.12K
AI content may include mistakes. Learn more
Google apps